Media Summary: The National Institute of Mental Health (NIMH) hosted a virtual workshop on the placebo effect. The purpose of this workshop was ... Lorenzo Piemonti, MD, Università Vita-Salute San Raffaele, Milan, Italy, addresses limitations in developing β Produced by Pharmaceutical Technology and BioPharm International Presenters: Alan Moore, Chief Strategy Officer, The ...

Episode 2 Challenges In Cell Therapy Translational Research - Detailed Analysis & Overview

The National Institute of Mental Health (NIMH) hosted a virtual workshop on the placebo effect. The purpose of this workshop was ... Lorenzo Piemonti, MD, Università Vita-Salute San Raffaele, Milan, Italy, addresses limitations in developing β Produced by Pharmaceutical Technology and BioPharm International Presenters: Alan Moore, Chief Strategy Officer, The ... Crystal Mackall, MD, Stanford University, Stanford, CA, outlines the main obstacles in developing dual-targeted chimeric antigen ... High-throughput live-cell imaging in the preclinical development of adoptive Watch the full course and our most up-to-date content here: Create a free account to track ...

Dr. Abdulkader Rahmo, PhD, President of SMSbiotech, delivers his keynote presentation, “Exploring Novel The webinar will run for 1 hour and will include a mixture of presentations and frequent interactions from the chairs, allowing for an ... This story highlights the GCTL services and one of their partnerships through a project that is testing a promising Masayo Takahashi, MD, PhD, RIKEN Center for Biosystems Dynamics

Photo Gallery

Episode 2: Challenges in Cell Therapy Translational Research
Challenges in Cell Therapy Translational Research
Day Two: Placebo Workshop: Translational Research Domains and Key Questions
Immunotherapy & CAR T Cells: Part 2
Episode 1: Opportunities in Cell Therapy Translational Research
Challenges in β cell replacement therapy
New research group to explore challenges in cell therapy
Episode 3: Impact of Raw Materials on Cell Therapy Development
Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies
Challenges of dual-targeted CAR T-cell therapy
Opportunities in Cell Therapy Translational Research
Case Study: Translational Research Unit, Oslo University Hospital
Sponsored
Sponsored
View Detailed Profile
Episode 2: Challenges in Cell Therapy Translational Research

Episode 2: Challenges in Cell Therapy Translational Research

Episode 2

Challenges in Cell Therapy Translational Research

Challenges in Cell Therapy Translational Research

http://www.thermofisher.com/kr/ko/home/clinical/clinical-

Sponsored
Day Two: Placebo Workshop: Translational Research Domains and Key Questions

Day Two: Placebo Workshop: Translational Research Domains and Key Questions

The National Institute of Mental Health (NIMH) hosted a virtual workshop on the placebo effect. The purpose of this workshop was ...

Immunotherapy & CAR T Cells: Part 2

Immunotherapy & CAR T Cells: Part 2

What

Episode 1: Opportunities in Cell Therapy Translational Research

Episode 1: Opportunities in Cell Therapy Translational Research

Episode

Sponsored
Challenges in β cell replacement therapy

Challenges in β cell replacement therapy

Lorenzo Piemonti, MD, Università Vita-Salute San Raffaele, Milan, Italy, addresses limitations in developing β

New research group to explore challenges in cell therapy

New research group to explore challenges in cell therapy

Cell therapy

Episode 3: Impact of Raw Materials on Cell Therapy Development

Episode 3: Impact of Raw Materials on Cell Therapy Development

Episode

Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies

Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies

Produced by Pharmaceutical Technology and BioPharm International Presenters: Alan Moore, Chief Strategy Officer, The ...

Challenges of dual-targeted CAR T-cell therapy

Challenges of dual-targeted CAR T-cell therapy

Crystal Mackall, MD, Stanford University, Stanford, CA, outlines the main obstacles in developing dual-targeted chimeric antigen ...

Opportunities in Cell Therapy Translational Research

Opportunities in Cell Therapy Translational Research

http://www.thermofisher.com/kr/ko/home/clinical/clinical-

Case Study: Translational Research Unit, Oslo University Hospital

Case Study: Translational Research Unit, Oslo University Hospital

High-throughput live-cell imaging in the preclinical development of adoptive

Impact of Raw Materials on Cell Therapy Development

Impact of Raw Materials on Cell Therapy Development

http://www.thermofisher.com/kr/ko/home/clinical/clinical-

What are the challenges of immunotherapy and T cell therapy? #myeloma

What are the challenges of immunotherapy and T cell therapy? #myeloma

Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track ...

Advanced Therapies Week 2026: Dr. Rahmo on Novel Cell Sources in Cell Therapy

Advanced Therapies Week 2026: Dr. Rahmo on Novel Cell Sources in Cell Therapy

Dr. Abdulkader Rahmo, PhD, President of SMSbiotech, delivers his keynote presentation, “Exploring Novel

ICRN/ENS-CCA Translational Science Series: Translating HER2-Directed Therapy in Biliary Tract Cancer

ICRN/ENS-CCA Translational Science Series: Translating HER2-Directed Therapy in Biliary Tract Cancer

The webinar will run for 1 hour and will include a mixture of presentations and frequent interactions from the chairs, allowing for an ...

ITHS Gene & Cell Therapy Lab: Exploring a Treatment for Advanced Ovarian Cancer

ITHS Gene & Cell Therapy Lab: Exploring a Treatment for Advanced Ovarian Cancer

This story highlights the GCTL services and one of their partnerships through a project that is testing a promising

Challenges in translating iPSC-based AMD therapies to the clinic

Challenges in translating iPSC-based AMD therapies to the clinic

Masayo Takahashi, MD, PhD, RIKEN Center for Biosystems Dynamics

Cell and Gene Therapies for Cancer: Future Promises and Challenges

Cell and Gene Therapies for Cancer: Future Promises and Challenges

View

23. TIL Talks #6 with Carolina BioOncology & BioCytics

23. TIL Talks #6 with Carolina BioOncology & BioCytics

In this